MetaCap

Propanc Biopharma Insider Trades

NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.78+0.055 (+3.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Propanc Biopharma insider activity

No Propanc Biopharma insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Nathanielsz James Andrew (CEO/CFO) reporting a transaction in 5,928,000 shares on Aug 17, 2021. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PPCB's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PPCB insider transactions

Propanc Biopharma insider transactions
DateInsiderTypeSharesValueFiling
Aug 17, 2021Kenyon Julian NormanChief Scientific OfficerAward3,420,000—Form 4
Aug 17, 2021Nathanielsz James AndrewCEO/CFOAward2,800,000—Form 4
Aug 17, 2021Nathanielsz James AndrewCEO/CFOAward5,928,000—Form 4
Feb 4, 2015Kenyon Julian NormanDirectorother17,654,470—Form 4
Feb 4, 2015Nathanielsz James AndrewCEO, CFO, Secretary, Treasurerother33,259,350—Form 4
Jul 5, 2013Nathanielsz James AndrewChief Executive OfficerSale55,000$4.98KForm 4
Jan 23, 2013Nathanielsz James AndrewChief Executive OfficerSale15,000$3.00KForm 4
Dec 13, 2012Nathanielsz James AndrewChief Executive OfficerSale5,500$1.10KForm 4
Sep 14, 2012Nathanielsz James AndrewChief Executive OfficerSale5,000$1.00KForm 4
Sep 4, 2012Nathanielsz James AndrewChief Executive OfficerSale250,000$50.00KForm 4
Aug 23, 2012Nathanielsz James AndrewChief Executive OfficerBuy250,000$50.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related